Search

Displaying results 4221 - 4230 of 5504 in total
  1. Drug

    KUR-113

    go.drugbank.com/drugs/DB18413
    Investigational

    It is being investigated as a bioactive bone graft substitute.

  2. Drug

    DDP-225

    go.drugbank.com/drugs/DB05642
    Investigational

    DDP225 is both a noradrenaline reuptake inhibitor and a serotonin type 3 receptor (5-HT3) antagonist. Noradrenaline and serotonin are neurotransmitters that are known to be involved in the control of the gastrointestinal system. The uniq...

  3. Drug

    Nicaraven

    go.drugbank.com/drugs/DB06397
    Experimental

  4. Drug

    Astodrimer

    go.drugbank.com/drugs/DB11854
    Investigational

    It is a lysine-based dendrimer with naphthalene disulfonic acid surface groups.

  5. Drug

    Theanine

    go.drugbank.com/drugs/DB12444
    Investigational

    It is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).

  6. Drug

    DAS-431 IV

    go.drugbank.com/drugs/DB05432
    Experimental

    DAS-431 IV is a dopamine D1 receptor agonist developed by DrugAbuse Sciences for the treatment of Addictions, Schizophrenia, Schizoaffective Disorders, Dementia, Parkinson's Disease, Strokes etc.

  7. Drug

    Lazucirnon

    go.drugbank.com/drugs/DB15269
    Investigational

    ALK-4290 is under investigation in clinical trial NCT03558061 (Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration).

  8. Drug

    XmAb24306

    go.drugbank.com/drugs/DB17526
    Investigational

    It is a heterodimeric interleukin (IL)-15/IL-15-receptor alpha (IL-15Ra) complex fused to a bispecific Fc domain.

  9. Drug

    Ozekibart

    go.drugbank.com/drugs/DB18675
    Investigational

    It is being investigated for the treatment of chondrosarcoma.

  10. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.